Dr Eskander on Pembrolizumab Plus Paclitaxel and Carboplatin

Ramez N. Eskander, MD, discusses findings from the phase 3 NRG GY018 trial of pembrolizumab plus chemotherapy in patients with endometrial cancer.

Related Keywords

Ramezn Eskander , , Reproductive Services , Department Of Obstetrics , Division Of Gynecologic Oncology , Gynecologic Oncology , California San Diego Moores Cancer Center , D , University Of California San Diego Moores Cancer Center , Nrg Gy018 Trial , Pembrolizumab Plus Chemotherapy , Patients With Endometrial Cancer , Nct03914612 ,